ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease
January 14, 2021RedHill Biopharma announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) ...
Pharma Sources Insight January 2025
